Evidence map›Paper›PMID 41967848›Full record

ArticleBioinformatics (Oxford, England)2026

DrugBLIP: exploring the protein-molecule interaction mechanisms with a multi-task learning graph transformer.

Rubo Wang, Xingyu Gao, Peilin Zhao

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rubo WangInstitute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029, China.
Xingyu GaoInstitute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029, China.ORCID 0000-0002-4660-8092
Peilin ZhaoSchool of Artificial Intelligence, Shanghai Jiao Tong University, Shanghai, 200230, China.

Funding

National Natural Science Foundation of China 62376264Science and Technology Innovation (STI) 2030-Major Projects 2022ZD0208700State Key Laboratory of Chemo and Biosensing (Hunan University)
6 · The paper itself

Abstract

motivationTraditional drug discovery methods are costly and inefficient, while existing deep learning approaches remain limited by task specificity and practical applicability. Accurately modeling protein-molecule interactions is critical for advancing virtual screening, docking, and drug design.

resultsWe propose DrugBLIP, a multi-task graph transformer model based on SE(3)-equivariant architectures, to unify protein-molecule interaction learning. By integrating contrastive learning, matching tasks, and docking optimization, DrugBLIP captures 3D spatial relationships through a hybrid graph transformer framework. Evaluations demonstrate state-of-the-art performance: DrugBLIP achieves an AUROC of 0.8217 and BEDROC of 0.5743 on virtual screening, outperforming traditional and deep learning baselines by 10%-127% across metrics. It also attains 91.2% top-1 docking success on CASF-2016 and 41.8% target fishing accuracy, showcasing robustness in diverse scenarios. Additionally, DrugBLIP reduces computational time by 700× compared to traditional docking tools. AVAILABILITY AND IMPLEMENTATION: Code is available at https://github.com/Wolkenwandler/DrugBLIP and archived at Zenodo with DOI: 10.5281/zenodo.16990700.

Indexed as

Computational BiologyDeep LearningDrug DiscoveryMolecular Docking SimulationProteinsSoftwareProtein BindingProteins

Identifiers

PMID41967848
PMCPMC13080933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.